Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Clinical Genitourinary Cancer
|
May 30, 2006
The role of bisphosphonates in the treatment of prostate cancer: recommendations from an expert panel
Fred Saad, Celestia S Higano, Oliver Sartor, et al.
The Journal of Sexual Medicine
|
May 15, 2007
A comparison of NCEP-ATPIII and IDF metabolic syndrome definitions with relation to metabolic syndrome-associated sexual dysfunction
Giovanni Corona, Edoardo Mannucci, Luisa Petrone, et al.
European Urology
|
March 28, 2006
Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction
Giovanni Corona, Edoardo Mannucci, Claude Schulman, et al.
European Urology
|
October 24, 2008
Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks
Hendrik Isbarn, Laurent Boccon-Gibod, Peter R Carroll, et al.
World Journal of Urology
|
March 4, 2020
Second generation of temporary implantable nitinol device (iTind) in men with LUTS: 2 year results of the MT-02-study
Gregor Kadner, Massimo Valerio, Ioannis Giannakis, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
July 12, 2024
Alternating Cystoscopy with Bladder EpiCheck<sup>®</sup> in the Surveillance of Low-Grade Intermediate-Risk NMIBC: A Cost Comparison Model
Yair Lotan, Georgios Gakis, Matteo Manfredi, et al.
BJU International
|
November 2, 2018
Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up
Francesco Porpiglia, Cristian Fiori, Daniele Amparore, et al.
The Journal of Sexual Medicine
|
April 15, 2010
Endocrine aspects of male sexual dysfunctions
Jacques Buvat, Mario Maggi, Louis Gooren, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
September 18, 2004
[Evaluation of the clinical benefit of Permixon and tamsulosin in severe BPH patients--PERMAL study subset analysis]
Frans Debruyne, Peter Boyle, Fernando Calais da Silva, et al.
Urology
|
February 25, 2003
Benign prostatic hyperplasia: a progressive disease of aging men
Mark Emberton, Gerald L Andriole, Jean de la Rosette, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Clinical Genitourinary Cancer
|
May 30, 2006
The role of bisphosphonates in the treatment of prostate cancer: recommendations from an expert panel
Fred Saad, Celestia S Higano, Oliver Sartor, et al.
The Journal of Sexual Medicine
|
May 15, 2007
A comparison of NCEP-ATPIII and IDF metabolic syndrome definitions with relation to metabolic syndrome-associated sexual dysfunction
Giovanni Corona, Edoardo Mannucci, Luisa Petrone, et al.
European Urology
|
March 28, 2006
Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction
Giovanni Corona, Edoardo Mannucci, Claude Schulman, et al.
European Urology
|
October 24, 2008
Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks
Hendrik Isbarn, Laurent Boccon-Gibod, Peter R Carroll, et al.
World Journal of Urology
|
March 4, 2020
Second generation of temporary implantable nitinol device (iTind) in men with LUTS: 2 year results of the MT-02-study
Gregor Kadner, Massimo Valerio, Ioannis Giannakis, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
July 12, 2024
Alternating Cystoscopy with Bladder EpiCheck<sup>®</sup> in the Surveillance of Low-Grade Intermediate-Risk NMIBC: A Cost Comparison Model
Yair Lotan, Georgios Gakis, Matteo Manfredi, et al.
BJU International
|
November 2, 2018
Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up
Francesco Porpiglia, Cristian Fiori, Daniele Amparore, et al.
The Journal of Sexual Medicine
|
April 15, 2010
Endocrine aspects of male sexual dysfunctions
Jacques Buvat, Mario Maggi, Louis Gooren, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
September 18, 2004
[Evaluation of the clinical benefit of Permixon and tamsulosin in severe BPH patients--PERMAL study subset analysis]
Frans Debruyne, Peter Boyle, Fernando Calais da Silva, et al.
Urology
|
February 25, 2003
Benign prostatic hyperplasia: a progressive disease of aging men
Mark Emberton, Gerald L Andriole, Jean de la Rosette, et al.
Page
of 5